Same formula, opposite destinies
Glucose and fructose are constitutional isomers sharing molecular formula C₆H₁₂O₆, but differing in carbonyl position: glucose is an aldohexose (aldehyde at C-1) and fructose is a ketohexose (ketone at C-2). One positional difference that determines absorption, hepatic processing, and long-term metabolic effects.
Structure: from open chain to ring
In aqueous solution, both exist predominantly as rings. Glucose forms a six-membered pyranose ring preferentially. Fructose forms a five-membered furanose ring (~67% in free solution). This conformational flexibility explains why cold fructose tastes 70% sweeter than glucose — the β-fructofuranose geometry fits especially well with the T1R2/T1R3 sweetness receptor.
| Property | Glucose | Fructose | |---|---|---| | Carbonyl type | Aldehyde (C-1) | Ketone (C-2) | | Preferred solution form | β-Pyranose (6-membered) | β-Furanose (5-membered) | | Relative sweetness | 74 (sucrose = 100) | 173 (cold, sucrose = 100) | | Glycemic index | 100 (reference) | 19–25 | | Intestinal absorption | SGLT1 (active, Na⁺-coupled) | GLUT5 (passive, no Na⁺) |
Intestinal absorption: two transporters, two speeds
Glucose uses the high-capacity SGLT1 cotransporter — active transport against concentration gradient. Absorbed glucose passes directly to portal blood and raises glycemia, triggering insulin release. Fructose uses GLUT5 — a low-capacity passive transporter. Intakes above 25–50 g of free fructose saturate GLUT5; excess reaches the colon and is fermented by microbiota, causing gas and osmotic diarrhea.
Hepatic metabolism: where the paths diverge
This is where the most important difference lies. Hepatic glucose enters glycolysis via glucokinase in a regulated step sensitive to insulin and substrate concentration. Hepatic fructose is phosphorylated by fructokinase with no regulatory feedback — it processes at maximum velocity regardless of concentration, entering glycolysis through a "back door" that bypasses all control checkpoints.
This unregulated processing drives three adverse metabolic consequences with chronic excess: hepatic de novo lipogenesis (3–5× greater than glucose), hyperuricemia (rapid ATP consumption raises AMP → uric acid), and leptin resistance (fructose doesn't stimulate satiety signaling proportionally).
Important context: fruit fructose is not the problem
Fructose in whole fruit does not produce the described negative effects — concentrations are low (4–9 g per serving), dietary fiber slows absorption, and polyphenols modulate hepatic metabolism. The documented adverse effects correspond to free fructose added in sweetened beverages and processed foods.